Depression in cerebral glioma patients: A systematic review of observational studies

Journal of the National Cancer Institute

Volumn 103, Issue 1, 2011, Pages 61-76

  Rooney, Alasdair G ^a   Carson, Alan ^a   Grant, Robin ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; TEMOZOLOMIDE;

ARTICLE; BECK DEPRESSION INVENTORY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE CONTROL STUDY; COGNITIVE DEFECT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; EMBASE; GLIOMA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MEDLINE; MORBIDITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMATIC REVIEW;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DEPRESSION; GLIOMA; HUMANS; INCIDENCE; OBSERVATION; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 78651287917     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq458     Document Type: Article

References (65)

1. Litofsky NS, Resnick AG. The relationships between depression and brain tumors. J Neurooncol. 2009;94:153-161.
2. Pangilinan PH, Kelly BM, Pangilinan JM. Depression in the patient with brain cancer. Community Oncol. 2007;4:533-536.
3. Weitzner MA. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest. 1999;17:285-291.
4. Mainio A, Hakko H, Niemela A, et al. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg. 2005;103:841-847.
5. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg. 1999;13(5): 480-485.
6. Cummings JL, Bogousslavsky J. Emotional consequences of focal brain lesions: an overview. In: Bogousslavsky J, Cummings JL, eds. Behavior and Mood Disorders in Focal Brain Lesions.Cambridge: Cambridge University Press; 2000:1-20.
7. Pace A, Pompili A. Depression in patients with high-grade glioma: results of the glioma project. Neurosurgery. 2005;56:E628-E629.
8. Wakefeld JC, Schmitz MF, First MB, et al. Extending the bereavement exclusion for major depression to other losses. Arch Gen Psychiatry. 2007;64:433-440.
9. Dalton SO, Laursen TM, Ross L, et al. Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol. 2009;27(9):1440- 1445.
10. Benros ME, Laursen TM, Dalton SO, et al. Psychiatric disorder as a frst manifestation of cancer: a 10-year population-based study. Int J Cancer. 2009;124:2917-2922.
11. Catt S, Chalmers A, Fallowfeld L. Psychosocial and supportive needs in high-grade glioma. Lancet Oncol. 2008;9:884-891.
12. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients. A meta-analysis. Cancer. 2009;115(22):5349-5361.
13. Gathinji M, McGirt MJ, Attenello FJ, et al. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol. 2009;71:299-303.
14. Wellisch DK, Kaleita TA, Freeman D, et al. Predicting major depression in brain tumor patients. Psychooncology. 2002;11:230-238.
15. Irle E, Peper M, Wowra B, et al. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol. 1994;51(2):164-174.
16. Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 1994;36:48-54.
17. Junck L. Supportive management in neuro-oncology: opportunities for patient care, teaching, and research. Curr Opin Neurol. 2004;17:649-653.
18. Pelletier G, Verhoef MJ, Khatri N, et al. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41-49.
19. Diaz JL, Barreto P, Gallego JM, et al. Proper information during the surgical decision-making process lowers the anxiety of patients with high-grade gliomas. Acta Neurochir. 2009;151:357-362.
20. Grant R, Slattery J, Gregor A, et al. Recording neurological impairment in clinical trials of glioma. J Neurooncol. 1994;19:37-49.
21. Litofsky NS, Farace E, Anderson F Jr, et al. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54(2):358-366.
22. Fox S, Lyon D, Farace E. Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh. 2007;39(1):61-67.
23. Giovagnoli AR. Quality of life in patients with stable disease after surgery, radiotherapy and chemotherapy for malignant brain tumour. J Neurol Neurosurg Psychiatry. 1999;67:358-363.
24. Hahn CA, Dunn RH, Logue PE, et al. Prospective study of neuropsycho-logic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys. 2003;55(4):992-999.
25. D'Angelo C, Mirijello A, Leggio L, et al. State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg. 2008;108:281-286.
26. Arnold SD, Forman LM, Brigidi BD, et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol. 2008;10:171-181.
27. Price TRP, Goetz KL, Lovell MR. Neuropsychiatric aspects of brain tumors. In: Yudofsky S, ed. The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences. Arlington, VA: American Psychiatric Publishing; 2002;735-742.
28. Giovagnoli AR, Tamburini M, Boiardi A. Quality of life in brain tumor patients. J Neurooncol. 1996;30:71-80.
29. McGovern P, Lautenbach E, Brennan PJ, et al. Risk factors for postcrani-otomy surgical site infection after 1,3-Bis (2-Chloroethyl)-1- Nitrosourea (Gliadel) wafer placement. Clin Infect Dis. 2003;36(6):759-765.
30. Brown PD, Ballman KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76:283-91.
31. Pringle AM, Taylor R, Whittle IR. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg. 1999;13(1):46-51.
32. Grafman J, Warden DL. Methodological issues in studying secondary mood disorders. In: Bogousslavsky J, Cummings JL, eds. Behavior and Mood Disorders in Focal Brain lesions.Cambridge: Cambridge University Press; 2000:48-64.
33. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
34. Desmond DW. The evaluation of mood and behavior in patients with focal brain lesions. In: Bogousslavsky J, Cummings JL, eds. Behavior and Mood Disorders in Focal Brain Lesions.Cambridge: Cambridge University Press; 2000.
35. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classifcation of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC; 2007.
36. Armstrong CL, Goldstein B, Cohen B, et al. Clinical predictors of depression in patients with low-grade brain tumors: consideration of a neurologic versus a psychogenic model. J Clin Psychol Med Settings. 2002;9(2):97-107.
37. Kaplan CP, Miner ME. Relationships: importance for patients with cerebral tumours. Brain Inj. 2000;14(3):251-259.
38. Kilbride L, Smith G, Grant R. The frequency and cause of anxiety and depression amongst patients with malignant brain tumours between surgery and radiotherapy. J Neurooncol. 2007;84:297-304.
39. Mainio A, Hakko H, Timonen M, et al. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005;56(6):1234-1242.
40. Mainio A, Hakko H, Niemela A, et al. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry. 2006;21:194-199.
41. Mainio A, Tuunanen S, Hakko H, et al. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256:516-521.
42. Rooney AG, Van Nieuwenhuizen D, Reijneveld J, et al. Female gender is not a proven risk factor for depression in glioma. J Neurooncol. 2009;95:449.
43. Armstrong CL, Hunter JV, Ledakis GE, et al. Late cognitive and radio-graphic changes related to radiotherapy. Neurology. 2002;59:40-48.
44. Davies E, Clarke C, Hopkins A. Malignant cerebral glioma, II: perspectives of patients and relatives on the value of radiotherapy. BMJ. 1996;313:1512-1516. (Pubitemid 27016885)
45. Edvardsson T, Pahlson A, Ahlstrom G. Experiences of onset and diagnosis of low-grade glioma from the patient's perspective. Cancer Nurs. 2006;29(5):415-422.
46. Feuerstein M, Hansen JA, Calvio LC, et al. Work productivity in brain tumor survivors. J Occup Environ Med. 2007;49(7):803-811.
47. Gregor A, Cull A, Traynor E, et al. Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol. 1996;41:55-59.
48. Sherwood PR, Given B, Given CW, et al. Predictors of distress in care-givers of persons with a primary malignant brain tumor. Res Nurs Health. 2006;29:105-120.
49. Siegel AM, Cascino GD, Fessler AJ, et al. Psychiatric comorbidity in 75 patients undergoing epilepsy surgery: lack of correlation with pathological fndings. Epilepsy Res. 2008;80(2-3):158-162.
50. Walker M, Brown J, Brown K, et al. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol. 2003;63:179-186.
51. Weitzner MA, Meyers CA, Gelke CK, et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75(5):1151-1161.
52. Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of frst and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003;98(6):1175-1181.
53. Giovagnoli AR, Silvani A, Colombo E, et al. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76:562-568.
54. Janda M, Stegina S, Langbecker D, et al. Quality of life among patients with a brain tumor and their carers. J Psychosom Res. 2007;63:617-623.
55. Steinbach JP, Blaicher HP, Herrlinger U, et al. Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology. 2006;66:239-242.
56. Taphoorn MJ, Heimans JJ, Snoek FJ, et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry. 1992;55:372-376.
57. Zbinden L, Pandey R, Schwindack C, et al. Information processing in patients with intracranial tumours: a preliminary evaluation of the clinical utility of inspection time. Br J Neurosurg. 2006;20(4):203-208.
58. Rees JH. Low-grade gliomas in adults. Curr Opin Neurol. 2002;15:657-661.
59. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4: 278-299.
60. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
61. Karnovsky DA, Burchenal JH. The clincal evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, eds. Evaluation of Chemotherapeutic Agents. New York, NY: Colombia University Press; 1949:191-205.
62. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
63. Reijs R, Aldenkamp AP, De Krom M. Mood effects of antiepileptic drugs. Epilepsy Behav. 2004;5:S66-S76.
64. Peduzzi P, Concato J, Kemper T, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373-1379.
65. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression Scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001;22(6):990-996.